Gastric Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Gastric Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies [Phase 2]
Phase 2 clinical trial evaluating a PD-1–blocking monoclonal antibody in combination with a metabolic modulator for several solid tumors is …
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma [Phase 2]
Phase 2 trial evaluating Suratadenoturev (OBP-301) in combination with pembrolizumab for esophagogastric adenocarcinoma; recruitment is ongo…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Study of Denikitug (GS-1811) Given Alone or With Nivolumab or Chemotherapy in Adults With Metastatic Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinomas [Phase 2]
Phase 2 clinical trial evaluating Denikitug (GS-1811) alone or with nivolumab or chemotherapy in adults with metastatic gastric, gastroesoph…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Adebrelimab Combined With Nab-paclitaxel, Oxaliplatin and Tegafur (AOS) for Perioperative Treatment of Locally Advanced Resectable GC/GEJ [Phase 2]
This Phase 2 trial investigates adebrelimab with nab-paclitaxel, oxaliplatin and tegafur (AOS) as perioperative therapy for locally advanced…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer [Phase 1]
A Phase 1 clinical trial evaluating ASP2138 given alone or with other cancer therapies in adults with gastric adenocarcinoma, gastroesophage…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers [Phase 1]
This update details a Phase 1 study evaluating DISP-10 in advanced gastrointestinal cancers, with the trial currently not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 3]
Phase 3 trial updating the design of a study comparing subcutaneous tislelizumab versus intravenous tislelizumab plus chemotherapy in unrese…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial is evaluating nivolumab added to standard therapy for advanced gastric and esophageal adenocarcinomas, incl…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Sintilimab Combined With Chemotherapy as Adjuvant Treatment for Phase III GC and GEJ [Phase 2]
Sintilimab plus chemotherapy is being evaluated as adjuvant therapy in a Phase 2 study for gastric adenocarcinoma and esophagogastric juncti…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Laparoscopic Staging for Stage III Gastric Cancer [NA]
Ongoing clinical trial evaluating laparoscopic staging for stage III gastric cancer; the study is currently enrolling by invitation.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating ASP546C in adults with gastric/GEJ adenocarcinoma, pancreatic adenocarcinoma, or other solid tumors is…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread [Phase 1, Phase 2]
A Phase 1/2 trial evaluating the dose of Zongertinib used alone or with other therapies in HER2-positive metastatic cancers, including breas…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors [Phase 1]
An ongoing Phase 1 trial is evaluating BL-M05D1 in patients with solid tumors, assessing safety, tolerability, pharmacokinetics, and prelimi…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors [Phase 1]
Plexium, Inc. is conducting a first-in-human Phase 1 study of PLX-61639 in locally advanced or metastatic solid tumors, and the trial is cur…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Costs of Opportunistic Upper Gastrointestinal Endoscopy and the Economic Burden of Gastric Cancer Management
This clinical trial update analyzes the costs of opportunistic upper gastrointestinal endoscopy and the economic burden of managing gastric …
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Ramucirumab (Cyramza), Nal-IRI (ONIVYDE) and Trifluridine/Tipiracil (Lonsurf) in Second Line Metastatic Gastric Cancer . [Phase 1, Phase 2]
Clinical trial update for a three-drug combination (ramucirumab, nanoliposomal irinotecan, and trifluridine/tipiracil) being studied in seco…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Phase 2 Study of Trastuzumab Deruxtecan in the Neoadjuvant Treatment, or Trastuzumab Deruxtecan Plus Capecitabine Plus Durvalumab(MEDI4736) in the Preoperative and Postoperative Adjuvant Treatment for Patients With HER2 Positive Gastric and Gastroesophageal Junction Adenocarcinoma [Phase 2]
This clinical trial update describes a Phase 2 study evaluating trastuzumab deruxtecan, with or without capecitabine and durvalumab, as neoa…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Peritoneal Metastasis, ROBO-CHIP Study [Phase 2]
A Phase 2 trial (ROBO-CHIP) from Mayo Clinic is evaluating robotic cytoreduction followed by hyperthermic intraperitoneal chemotherapy for g…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma [Phase 3]
A Phase 3 trial is evaluating mFOLFIRINOX versus mFOLFOX with or without nivolumab for HER2-negative advanced, unresectable, or metastatic e…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Observational Study of Patients Treated With Nivolumab and Chemotherapy for Advanced or Metastatic Esophageal, Gastroesophageal or Gastric Cancer in France
An observational study in France evaluating outcomes for patients with advanced gastric and esophageal cancers treated with nivolumab in com…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial update for IDE892 evaluating monotherapy and combination in MTAP-deleted advanced solid tumors. The study is currentl…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: A Study of Disitamab Vedotin, Tunlametinib, and PD-1 Antibody for Advanced Gastric Cancer [Phase 2]
A Phase 2 clinical trial is evaluating Disitamab Vedotin, Tunlametinib, and a PD-1 antibody for advanced gastric adenocarcinoma; the study i…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: A Study to Evaluate the Adverse Events, Efficacy, and Optimal Dose of Intravenous (IV) ABBV-400 in Combination With IV Fluorouracil, Leucovorin, and Budigalimab in Adult Participants With Locally Advanced Unresectable or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma [Phase 2]
Phase 2 clinical trial evaluating the adverse events, efficacy, and optimal dose of ABBV-400 in combination with fluorouracil, leucovorin, a…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity [Phase 2, Phase 3]
A Phase 2/3 clinical trial is evaluating the addition of Paclitaxel administered intraperitoneally with standard chemotherapy for gastric ca…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body [Phase 3]
A Phase 3 trial is evaluating whether adding radiotherapy to standard chemotherapy improves outcomes for patients with metastatic esophageal…